FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377696189> ?p ?o ?g. }

• W4377696189 endingPage "109579" @default.
• W4377696189 startingPage "109579" @default.
• W4377696189 abstract "Bivalent COVID-19 vaccines that contain two mRNAs encoding Wuhan-1 and Omicron BA.4/5 spike proteins are successful in preventing infection from the original strain and Omicron variants, but the quality of adaptive immune responses is still not well documented. This study aims at characterizing adaptive immune responses to the bivalent booster vaccination in 46 healthy participants. Plasma and PBMC were collected prior and three weeks after bivalent booster. We measured anti-N, anti-S, and RBD IgM, IgA, IgG plasma titers against original, Omicron BA.1, and BA.5 variants (pending) as well as total anti-S IgG titers and surrogate Virus Neutralization capacity against the Alpha, Delta, and BA.1 variant. With spectral flow-cytometry we identified peripheral blood B-cells specific for the RBD of the S-protein of the original and BA.1 variants. T-cell-specific responses were assessed by cytokine release assay after stimulation with SARS-CoV-2 peptides from the original, BA.1, BA.4, and BA.5 variants (pending). Finally, we performed TRB and IGH repertoire studies on sorted CD4+, CD8+, CD19+ lymphocytes, to study breadth of SARS-CoV-2 specific clonotypes (pending). 27/46 participants were analyzed; 9 had SARS-CoV-2 infection (COVID+), while 18 are infection naïve (COVID-). In both groups, median time since last dose of SARS-CoV-2 vaccine (3rd or 4th) was 11 months. All subjects were positive for anti-S IgG prior to bivalent booster. The COVID + group displayed anti-S IgG pre-booster levels and neutralization against BA.1 higher than the COVID- group. Significant increase post-boost of total anti-S IgG and BA.1 neutralizing activity was detected in the COVID- but not in the COVID+ group; however, no difference in neutralization activity post-boost was detected between the two groups. Furthermore, the COVIDgroup showed significant increase in the frequency of CD19+ and CD27+ switched memory B-cells specific for BA.1 RBD in post-boost compared to pre-boost samples. However, post-boost frequencies of the same B-cells were higher in the COVID+ compared to the COVID- group. These preliminary findings confirm that among individual immunized with the original COVID-19 mRNAvaccine, prior COVID infection provides increased protection against SARS-CoV-2 variants. They also demonstrate that booster immunization with the bivalent vaccine induces robust adaptive immune responses against Omicron variant.Download : Download high-res image (102KB)Download : Download full-size imageFigure 1. Neutralization capacity against the BA.1 variant in patients pre and post bivalent booster. Positive ≥30% binding inhibition.Download : Download high-res image (240KB)Download : Download full-size imageFigure 2. Spectral flow-cytometry of peripheral blood B-cells spécifie for the RBD of the S-protein of the original and BA.1 variants for COVID positive (+) and COVID négative (-) participants. Figure 1. Neutralization capacity against the BA.1 variant in patients pre and post bivalent booster. Positive ≥30% binding inhibition. Figure 2. Spectral flow-cytometry of peripheral blood B-cells spécifie for the RBD of the S-protein of the original and BA.1 variants for COVID positive (+) and COVID négative (-) participants." @default.
• W4377696189 created "2023-05-24" @default.
• W4377696189 creator A5002913856 @default.
• W4377696189 creator A5021239338 @default.
• W4377696189 creator A5025431753 @default.
• W4377696189 creator A5028118110 @default.
• W4377696189 creator A5029163913 @default.
• W4377696189 creator A5031889435 @default.
• W4377696189 creator A5041450311 @default.
• W4377696189 creator A5051473743 @default.
• W4377696189 creator A5071836467 @default.
• W4377696189 creator A5077001119 @default.
• W4377696189 date "2023-05-01" @default.
• W4377696189 modified "2023-09-23" @default.
• W4377696189 title "Characterization of Adaptive Immune Responses to SARS-CoV-2 Updated Bivalent Booster" @default.
• W4377696189 doi "https://doi.org/10.1016/j.clim.2023.109579" @default.
• W4377696189 hasPublicationYear "2023" @default.
• W4377696189 type Work @default.
• W4377696189 citedByCount "0" @default.
• W4377696189 crossrefType "journal-article" @default.
• W4377696189 hasAuthorship W4377696189A5002913856 @default.
• W4377696189 hasAuthorship W4377696189A5021239338 @default.
• W4377696189 hasAuthorship W4377696189A5025431753 @default.
• W4377696189 hasAuthorship W4377696189A5028118110 @default.
• W4377696189 hasAuthorship W4377696189A5029163913 @default.
• W4377696189 hasAuthorship W4377696189A5031889435 @default.
• W4377696189 hasAuthorship W4377696189A5041450311 @default.
• W4377696189 hasAuthorship W4377696189A5051473743 @default.
• W4377696189 hasAuthorship W4377696189A5071836467 @default.
• W4377696189 hasAuthorship W4377696189A5077001119 @default.
• W4377696189 hasBestOaLocation W43776961891 @default.
• W4377696189 hasConcept C137061746 @default.
• W4377696189 hasConcept C159047783 @default.
• W4377696189 hasConcept C159654299 @default.
• W4377696189 hasConcept C167672396 @default.
• W4377696189 hasConcept C178790620 @default.
• W4377696189 hasConcept C185592680 @default.
• W4377696189 hasConcept C202751555 @default.
• W4377696189 hasConcept C203014093 @default.
• W4377696189 hasConcept C2776620830 @default.
• W4377696189 hasConcept C2778957590 @default.
• W4377696189 hasConcept C32611913 @default.
• W4377696189 hasConcept C54355233 @default.
• W4377696189 hasConcept C544153396 @default.
• W4377696189 hasConcept C553184892 @default.
• W4377696189 hasConcept C71924100 @default.
• W4377696189 hasConcept C86803240 @default.
• W4377696189 hasConcept C8891405 @default.
• W4377696189 hasConceptScore W4377696189C137061746 @default.
• W4377696189 hasConceptScore W4377696189C159047783 @default.
• W4377696189 hasConceptScore W4377696189C159654299 @default.
• W4377696189 hasConceptScore W4377696189C167672396 @default.
• W4377696189 hasConceptScore W4377696189C178790620 @default.
• W4377696189 hasConceptScore W4377696189C185592680 @default.
• W4377696189 hasConceptScore W4377696189C202751555 @default.
• W4377696189 hasConceptScore W4377696189C203014093 @default.
• W4377696189 hasConceptScore W4377696189C2776620830 @default.
• W4377696189 hasConceptScore W4377696189C2778957590 @default.
• W4377696189 hasConceptScore W4377696189C32611913 @default.
• W4377696189 hasConceptScore W4377696189C54355233 @default.
• W4377696189 hasConceptScore W4377696189C544153396 @default.
• W4377696189 hasConceptScore W4377696189C553184892 @default.
• W4377696189 hasConceptScore W4377696189C71924100 @default.
• W4377696189 hasConceptScore W4377696189C86803240 @default.
• W4377696189 hasConceptScore W4377696189C8891405 @default.
• W4377696189 hasLocation W43776961891 @default.
• W4377696189 hasLocation W43776961892 @default.
• W4377696189 hasOpenAccess W4377696189 @default.
• W4377696189 hasPrimaryLocation W43776961891 @default.
• W4377696189 hasRelatedWork W1970618862 @default.
• W4377696189 hasRelatedWork W1972745941 @default.
• W4377696189 hasRelatedWork W1973803488 @default.
• W4377696189 hasRelatedWork W1984647379 @default.
• W4377696189 hasRelatedWork W2002606273 @default.
• W4377696189 hasRelatedWork W2006837492 @default.
• W4377696189 hasRelatedWork W2392106974 @default.
• W4377696189 hasRelatedWork W2414181163 @default.
• W4377696189 hasRelatedWork W4361889586 @default.
• W4377696189 hasRelatedWork W4361934749 @default.
• W4377696189 hasVolume "250" @default.
• W4377696189 isParatext "false" @default.
• W4377696189 isRetracted "false" @default.
• W4377696189 workType "article" @default.